Avantor, Inc. reports developments as a life science tools company supplying mission-critical products and services to life sciences and advanced technology customers through its VWR Distribution & Services and Bioscience & Medtech Products businesses. Recurring updates cover earnings, cash flow, leverage, guidance, segment performance and the company’s Revival transformation program, including VWR brand activity, manufacturing and supply-chain improvements and e-commerce upgrades.
Company news also covers portfolio and infrastructure actions such as Masterflex fluid handling systems, single-use assemblies, peristaltic pumps, J.T. Baker high-purity process chemicals, and expanded microbial and stability testing capabilities for regulated biopharma manufacturing. Governance and management updates include finance leadership changes and appointments tied to bioscience, medtech products and enterprise transformation.
Avantor, Inc. (NYSE: AVTR) has declared a quarterly cash dividend of $0.78 per share for its 6.250% Series A Mandatory Convertible Preferred Stock, representing a yield of 1.560%. This dividend will be payable on February 15, 2021 to shareholders on record as of February 1, 2021. The company emphasizes its commitment to enhancing shareholder value while maintaining a strong global presence in the life sciences and advanced materials sectors.
Avantor, a global provider of mission-critical products and services, will announce its fourth quarter and full year 2020 financial results after the market closes on February 3, 2021. A conference call to discuss these results will be held at 5:00 p.m. ET on the same day. Participants can join via phone or through a live webcast on the company's website. Avantor serves more than 225,000 customer locations globally, operating in key industries such as biopharma and healthcare.
Avantor (NYSE: AVTR) announced preliminary unaudited revenues for Q4 2020, estimating approximately $1.79B, reflecting an organic revenue growth of ~15%. The free cash flow is estimated at over $270M, significantly higher than $74.9M in Q4 2019. The results, to be finalized soon, align with the company's ongoing performance in life sciences and advanced materials. Management will present 2021 revenue expectations at the J.P. Morgan Healthcare Conference. Notably, these preliminary results are unaudited and may change upon final review.
Avantor (NYSE: AVTR) has announced a global initiative to support communities amid the COVID-19 pandemic. The company is donating over 1.5 million surgical masks and thermometers to schools in Mumbai and Delhi. Additionally, Avantor Foundation has granted nearly $350,000 to various organizations focusing on healthcare and STEM education. These efforts align with Avantor's mission to promote science for goodness and enhance patient outcomes through educational support and healthcare improvements.
Avantor, a leading provider of mission-critical products and services, will participate in the 39th Annual J.P. Morgan Healthcare Conference on January 11, 2021. CEO Michael Stubblefield will represent the company in a segment starting at approximately 9:10 a.m. Eastern Time. Investors can access a live webcast on Avantor's investor relations website, which will be available for replay until January 31, 2021.
With a global reach, Avantor serves over 225,000 customer locations in more than 180 countries, supporting critical research and development activities.
Avantor (NYSE: AVTR) will participate in the Evercore ISI 3rd Annual HealthCONx Virtual Conference on December 2, 2020. The event will feature a segment with Michael Stubblefield, President and CEO, starting at approximately 2:40 p.m. ET. Investors can access the live webcast via Avantor's investor relations website, and it will be available for replay until December 31, 2020. Avantor is a global leader in providing mission-critical products and services to various industries, supporting over 225,000 customer locations worldwide.
Avantor, Inc. (NYSE: AVTR) has launched a new biorepository and sample archiving facility in Frankfurt, Germany, enhancing access to samples within 24 hours for researchers. This facility is crucial for the growing demand for clinical trials, especially during the COVID-19 pandemic. Avantor boasts a 40-year heritage in biorepository services, having stored over 100 million research assets without failure. The facility has earned DGNB 'Gold' certification for sustainable construction, underscoring Avantor's commitment to ecological and economic responsibility.
Avantor, a leading global provider of mission-critical products, will participate in the Jefferies Virtual London Healthcare Conference on November 18, 2020. Michael Stubblefield, President and CEO of Avantor, is scheduled to speak at approximately 11:25 a.m. Eastern Time. Investors and attendees can access a live webcast through Avantor's investor relations website, with a replay available until November 30, 2020. Avantor serves over 225,000 customer locations globally, supporting vital research across various industries.
Avantor (NYSE: AVTR) has partnered with G-CON Manufacturing to provide mobile lab units, known as LabPODs, aimed at expediting diagnostic testing, particularly for COVID-19. These mobile labs will allow for quicker on-site testing, reducing wait times for results and potentially slowing infection rates. Avantor will supply the necessary equipment and expertise for these labs, enhancing diagnostic capabilities not only for COVID-19 but also for other microbial and analytical evaluations. This collaboration represents a significant step in transforming the accessibility of critical testing services.
Avantor, a global provider of mission-critical products and services, announced the pricing of a secondary offering of 71,569,765 shares of its common stock at $25.25 per share. This offering, conducted by certain stockholders including New Mountain Capital, reflects an increase from the initially proposed 71,339,001 shares. The underwriters have a 30-day option to purchase up to an additional 7,156,975 shares. The offering is expected to close on November 10, 2020.